The Minister of Health Amrillo Inoyatov said that two drug production agreements were signed during Shavkat Mirziyoyev’s visit to Singapore
Meinhardt Group has been commissioned to a pharmaceutical unit producing immunobiological drugs, with a total value of 49 million dollars.
According to the contract, the following drugs used in the prevention and treatment of diseases will be manufactured:
- vaccine, anatoxin, probiotic and eubiotics;
- immunoglobulin and immune sera, monoclonal antibodies obtained by genetic engineering;
- immunomodulators used in immune correction, treatment and prevention of immune deficiency (interleukin, interferon, thymus hormones, myelopeptides, tumor necrosis factor, growth factors, etc.).
In addition, it was agreed to implement a project worth 100 million dollars aimed at establishing a biopharmaceutical complex for the preparation of drugs based on stem cells with the Uzbekistan-Singapore investment firm, which is being opened in cooperation with SiPiJi International.
Comments (0)